Page values for "Rituximab"
Jump to navigation
Jump to search
"_pageData" values
1 row is stored for this page| Field | Field type | Value |
|---|---|---|
| _pageID | Integer | 862,513 |
| _pageName | Page | Rituximab |
| _pageTitle | String | Rituximab |
| _pageNamespace | Integer | 0 |
"definitions" values
1 row is stored for this page| Field | Field type | Value |
|---|---|---|
| Term | Page | Rituximab |
| Short_definition | String | Rituximab - (pronounced) (rih-TUK-sih-mab) drug used alone or with other drugs under the brand names Riabni, Rituxan, Ruxience, and Truxima to treat certain types of B-cell non-Hodgkin's lymphoma, chronic lymphocytic leukemia, and acute B-cell leukemia who are CD20 positive. Rituximab is also being |
| Type | Page | Cancer terms |
| Specialty | Page | Oncology |
| Language | Page | English |
| Source | Page | NCI |
| Comments | String |